Iovance Biotherapeutics Inc. buy Chardan Capital
Start price
10.08.23
/
50%
€6.49
Target price
10.08.24
€26.26
Performance (%)
13.98%
Price
08:01
€7.59
Summary
This prediction is currently active. The prediction currently has a performance of 13.98%. This prediction currently runs until 10.08.24. The prediction end date can be changed by Chardan_Capital at any time. Chardan_Capital has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Iovance Biotherapeutics Inc. | -2.476% | -2.476% |
iShares Core DAX® | -0.284% | -1.519% |
iShares Nasdaq 100 | 3.902% | 5.242% |
iShares Nikkei 225® | 2.335% | 1.663% |
iShares S&P 500 | 2.818% | 2.879% |
Comments by Chardan_Capital for this prediction
In the thread Iovance Biotherapeutics Inc. diskutieren
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $29.00 price target on the stock.
Ratings data for IOVA provided by MarketBeat
Stopped prediction by Chardan_Capital for Iovance Biotherapeutics Inc.
Iovance Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€10.58
20.02.24
20.02.24
€31.41
20.02.25
20.02.25
-28.28%
08:01
08:01
Iovance Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€6.53
16.08.23
16.08.23
€26.61
16.08.24
16.08.24
16.24%
08:01
08:01
Iovance Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€6.85
01.03.23
01.03.23
€27.17
01.03.24
01.03.24
127.70%
02.03.24
02.03.24